From: Intra-abdominal pressure and abdominal perfusion pressure in cirrhotic patients with septic shock
 | All patients | IAPa < 12 mmHg | IAPa ≥ 12 mmHg | p value | APPa ≥ 60 mmHg | APPa < 60 mmHg | p value |
---|---|---|---|---|---|---|---|
 | N = 61 | N = 11 | N = 50 |  | N = 18 | N = 43 |  |
Age in years, mean ± SD | 59.8 ± 12.2 | 63.6 ± 7.4 | 59.0 ± 13.0 | 0.26 | 59.0 ± 14.2 | 60.2 ± 11.5 | 0.74 |
Male sex, N (%) | 36 (59.0) | 7 (63.7) | 29 (58.0) | 1.00 | 7 (38.9) | 18 (41.9) | 0.83 |
Body mass index (Kg/m2), mean ± SD | 26.8 ± 5.9 | 26.5 ± 6.3 | 26.9 ± 5.9 | 0.87 | 26.3 ± 6.5 | 27.0 ± 5.8 | 0.70 |
Etiology of liver cirrhosis, N (%) | Â | Â | Â | Â | Â | Â | Â |
   Hepatitis C | 30 (49.2) | 8 (73.0) | 22 (44.0) |  | 7 (39.0) | 23 (53.0) |  |
   Hepatitis B | 17 (27.9) | 2 (18.0) | 15 (30.0) | 0.27 | 6 (33.0) | 11 (26.0) | 0.56 |
   Others | 14 (23.0) | 1 (9.0) | 13 (26.0) |  | 5 (28.0) | 9 (21.0) |  |
Child-Pugh score, mean ± SD | 11.6 ± 1.6 | 11.2 ± 1.4 | 11.6 ± 1.6 | 0.39 | 11.2 ± 1.9 | 11.7 ± 1.4 | 0.29 |
APACHE II score, mean ± SD | 30.1 ± 7.5 | 23.9 ± 7.7 | 31.5 ± 6.7 | 0.002 | 29.9 ± 7.8 | 30.2 ± 7.4 | 0.91 |
SOFA score, mean ± SD | 14.9 ± 3.7 | 12.5 ± 4.5 | 15.4 ± 3.3 | 0.02 | 13.9 ± 3.7 | 15.3 ± 3.7 | 0.1 |
   SOFA renal sub-score | 2.2 ± 1.4 | 2.0 ± 1.7 | 2.3 ± 1.3 | 0.52 | 1.7 ± 1.4 | 2.5 ± 1.3 | 0.06 |
SBP, N (%) | 19 (31.1) | 7 (63.6) | 12 (24.0) | 0.03 | 5 (27.8) | 14 (32.6) | 0.71 |
Encephalopathy, N (%) | 42 (68.9) | 4 (36.4) | 38 (76.0) | 0.03 | 11 (61.1) | 31 (72.1) | 0.28 |
Ascites, N (%) | 58 (95.1) | 11 (100) | 47 (94.0) | 0.05 | 16 (88.9) | 42 (97.7) | 0.26 |
Mechanically ventilated, N (%) | 51 (83.6) | 6 (54.5) | 45 (90.0) | 0.01 | 16 (88.9) | 35 (81.4) | 0.71 |
PaO2/FiO2 ratio (mmHg), mean ± SD | 252 ± 141 | 261 ± 129 | 250 ± 144 | 0.83 | 194 ± 117 | 277 ± 144 | 0.04 |
Norepinephrine dose at inclusion (μg/kg/min), mean ± SD | 0.35 ± 0.35 | 0.20 ± 0.29 | 0.39 ± 0.35 | 0.11 | 0.26 ± 0.34 | 0.39 ± 0.35 | 0.21 |
Creatinineb (μmol/l), mean ± SD | 289 ± 165 | 299 ± 176 | 286 ± 165 | 0.81 | 239 ± 147 | 309 ± 170 | 0.13 |
INR, mean ± SD | 2.8 ± 1.4 | 2.6 ± 1.5 | 2.8 ± 1.4 | 0.71 | 2.4 ± 0.7 | 2.9 ± 1.6 | 0.08 |
Bilirubinb (μmol/l), mean ± SD | 340.3 ± 284.3 | 146.0 ± 193.5 | 383.1 ± 284.6 | 0.01 | 313.3 ± 305.2 | 351.7 ± 278.1 | 0.63 |
Ammoniab (μmol/l), mean ± SD | 110.2 ± 101.1 | 74.7 ± 41.1 | 118.0 ± 108.8 | 0.03 | 111.6 ± 167.2 | 109.6 ± 57.4 | 0.96 |
Albumin (g/l), mean ± SD | 32.5 ± 7.1 | 33.8 ± 8.1 | 32.2 ± 6.9 | 0.50 | 31.5 ± 5.4 | 32.9 ± 7.7 | 0.48 |
Hemoglobin (g/dl), mean ± SD | 8.6 ± 1.6 | 9.4 ± 1.6 | 8.4 ± 1.6 | 0.27 | 8.3 ± 1.5 | 8.7 ± 1.6 | 0.42 |
Lactate levelb (mmol/l), mean ± SD | 4.4 ± 4.3 | 3.7 ± 4.6 | 4.5 ± 4.2 | 0.59 | 2.9 ± 2.2 | 5.0 ± 4.8 | 0.02 |
Fluid intake in day 1 (ml), mean ± SD | 4,356 ± 2,574 | 3,993 ± 1,877 | 4,436 ± 2,712 | 0.61 | 4,015 ± 2,486 | 4,499 ± 3,336 | 0.51 |
Fluid balance in day 1 (ml), mean ± SD | 3,177 ± 2,919 | 1,544 ± 2,980 | 3,537 ± 4,335 | 0.04 | 2,368 ± 2,913 | 3,516 ± 2,887 | 0.16 |
MAP day 1 (mmHg), mean ± SD | 70.7 ± 7.2 | 58.8 ± 5.8 | 59.4 ± 8.1 | 0.83 | 63.3 ± 7.1 | 57.6 ± 7.3 | 0.007 |
CVP day 1 (mmHg), mean ± SD | 15.5 ± 6.2 | 12.3 ± 4.0 | 16.2 ± 6.4 | 0.054 | 14.1 ± 6.5 | 16.1 ± 6.1 | 0.28 |
IAP day 1 (mmHg), mean ± SD | 15.3 ± 4.7 | 9.0 ± 2.2 | 16.7 ± 3.9 | < 0.0001 | 12.8 ± 3.8 | 16.3 ± 4.7 | 0.008 |
APP day 1 (mmHg), mean ± SD | 55.5 ± 7.7 | 59.4 ± 6.2 | 54.6 ± 7.8 | 0.06 | 64.7 ± 5.4 | 51.6 ± 4.7 | < 0.0001 |
Randomization, N (%) | Â | Â | Â | Â | Â | Â | Â |
   Hydrocortisone | 32 (52.5) | 4 (36.4) | 28 (56.0) | 0.24 | 14 (77.8) | 18 (41.9) | 0.01 |
   Placebo | 29 (47.5) | 7 (63.6) | 22 (44.0) |  | 4 (22.2) | 25 (58.1) |  |